tiprankstipranks
Advertisement
Advertisement
Viatris raises FY26 adjusted EPS view to $2.45-$2.59 from $2.33-$2.47
PremiumThe FlyViatris raises FY26 adjusted EPS view to $2.45-$2.59 from $2.33-$2.47
28d ago
Viatris, Inc. (VTRS) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Viatris, Inc. (VTRS) Q2 Earnings Cheat Sheet
30d ago
Viatris receives FDA approval for Gwyn Lo contraceptive patch
Premium
The Fly
Viatris receives FDA approval for Gwyn Lo contraceptive patch
1M ago
Viatris price target raised to $22 from $17 at Barclays
PremiumThe FlyViatris price target raised to $22 from $17 at Barclays
4M ago
Viatris says FDA accepts for review NDA for MR-107A-02
Premium
The Fly
Viatris says FDA accepts for review NDA for MR-107A-02
4M ago
Einhorn’s DME takes stakes in StubHub, Paramount, buys more Peloton
Premium
The Fly
Einhorn’s DME takes stakes in StubHub, Paramount, buys more Peloton
4M ago
Viatris reports Q1 adjusted EPS 59c, consensus 50c
PremiumThe FlyViatris reports Q1 adjusted EPS 59c, consensus 50c
4M ago
Viatris backs FY26 adjusted EPS view $2.23-$2.47, consensus $2.44
Premium
The Fly
Viatris backs FY26 adjusted EPS view $2.23-$2.47, consensus $2.44
4M ago
Viatris Delivers Strong Q1 2026 Results, Reaffirms Guidance
Premium
Company Announcements
Viatris Delivers Strong Q1 2026 Results, Reaffirms Guidance
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100